首页 > 最新文献

中国医学科学院学报最新文献

英文 中文
Remitting Seronegative Symmetrical Synovitis With Pitting Edema Syndrome With Fever as the First Clinical Manifestation:Report of One Case. 以发热为首发临床表现的缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征1例报告
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.15977
Tian-Chang Zhong, Zi-Hao Fang, Ying-Yan Wen, Kang-An Lai, Jia-Chun Li

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare seronegative synovial inflammatory disease in which fever is a rare symptom.There are few case reports of RS3PE syndrome with fever as the first clinical manifestation in China.In this paper,we report a case of RS3PE syndrome with fever as the first symptom and diagnosed by systematic fever investigation.

缓解性血清阴性对称性滑膜炎伴凹陷性水肿(RS3PE)综合征是一种罕见的血清阴性滑膜炎症性疾病,其中发烧是一种罕见的症状。目前国内以发热为首发临床表现的RS3PE综合征病例报道较少。本文报告1例RS3PE综合征,以发热为首发症状,通过系统发热调查确诊。
{"title":"Remitting Seronegative Symmetrical Synovitis With Pitting Edema Syndrome With Fever as the First Clinical Manifestation:Report of One Case.","authors":"Tian-Chang Zhong, Zi-Hao Fang, Ying-Yan Wen, Kang-An Lai, Jia-Chun Li","doi":"10.3881/j.issn.1000-503X.15977","DOIUrl":"10.3881/j.issn.1000-503X.15977","url":null,"abstract":"<p><p>Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare seronegative synovial inflammatory disease in which fever is a rare symptom.There are few case reports of RS3PE syndrome with fever as the first clinical manifestation in China.In this paper,we report a case of RS3PE syndrome with fever as the first symptom and diagnosed by systematic fever investigation.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"970-973"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Progress of Drugs in Prevention and Treatment of Nephrolithiasis. 预防和治疗肾炎药物的研究进展。
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.15987
Sha-Sha Xia, Jun Shen, Kai-Wen Shen, Qiang Wang, Wei-Hu Cen

With the improvement of people's living standards,the incidence of nephrolithiasis is increasing year by year.Nephrolithiasis poses a serious threat to the patients due to the unclear etiology,complicated composition of stones,and high recurrence rate after surgery.As the research on the pathogenesis and pathophysiology of nephrolithiasis keeps deepening in recent years,researchers have made achievements in the drug treatment,which has become a hot topic for urologists.This paper reviews the advances in the research on the possible formation mechanism and drug-induced litholysis and prevention for nephrolithiasis,aiming to provide theoretical references for subsequent clinical research.

随着人们生活水平的提高,肾结石的发病率逐年上升。肾结石病因不清、结石成分复杂、术后复发率高,给患者带来严重威胁。近年来,随着对肾结石发病机制和病理生理学研究的不断深入,研究人员在药物治疗方面也取得了一定的成果,成为泌尿外科医生的热门话题。本文综述了肾结石可能的形成机制、药物溶石及预防等方面的研究进展,旨在为后续的临床研究提供理论参考。
{"title":"Research Progress of Drugs in Prevention and Treatment of Nephrolithiasis.","authors":"Sha-Sha Xia, Jun Shen, Kai-Wen Shen, Qiang Wang, Wei-Hu Cen","doi":"10.3881/j.issn.1000-503X.15987","DOIUrl":"10.3881/j.issn.1000-503X.15987","url":null,"abstract":"<p><p>With the improvement of people's living standards,the incidence of nephrolithiasis is increasing year by year.Nephrolithiasis poses a serious threat to the patients due to the unclear etiology,complicated composition of stones,and high recurrence rate after surgery.As the research on the pathogenesis and pathophysiology of nephrolithiasis keeps deepening in recent years,researchers have made achievements in the drug treatment,which has become a hot topic for urologists.This paper reviews the advances in the research on the possible formation mechanism and drug-induced litholysis and prevention for nephrolithiasis,aiming to provide theoretical references for subsequent clinical research.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":" ","pages":"918-923"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the Pathogenesis of Hereditary Angioedema. 遗传性血管性水肿发病机制的研究进展。
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.15915
Xiang-Yi Cui, Yu-Xiang Zhi

Hereditary angioedema (HAE) is a rare,unpredictable,autosomal dominant disorder characterized by recurrent swelling in subcutaneous and submucosal tissue.In recent years,the pathophysiology and pathogenesis of HAE have been continuously studied and elucidated.In addition to the genes encoding complement 1 esterase inhibitors,new pathogenic variants have been identified in the genes encoding coagulation factor Ⅻ,plasminogen,angiopoietin-1,kininogen,heparan sulfate 3-O-sulfotransferase 6,and myoferlin in HAE.Moreover,different pathogenic variants have different mechanisms in causing HAE.In addition,the pathogenic genes of some patients remain unknown.This review summarizes the recent progress in the classification,epidemiology,pathophysiology,and pathogenesis of HAE,aiming to provide ideas for further fundamental research,clinical diagnosis,and drug development of HAE.

遗传性血管性水肿(HAE)是一种罕见的、不可预测的常染色体显性遗传病,其特征是皮下和粘膜下组织反复肿胀。近年来,HAE的病理生理和发病机制不断被研究和阐明。除了编码补体1酯酶抑制剂的基因外,在HAE中还发现了新的致病变异,包括编码凝血因子Ⅻ、纤溶酶原、血管生成素-1、激肽原、硫酸肝素3- o -硫转移酶6和肌钙素的基因。此外,不同的致病变异在引起HAE时有不同的机制。此外,一些患者的致病基因仍然未知。本文综述了近年来在HAE的分类、流行病学、病理生理、发病机制等方面的研究进展,旨在为进一步开展HAE的基础研究、临床诊断和药物开发提供思路。
{"title":"Advances in the Pathogenesis of Hereditary Angioedema.","authors":"Xiang-Yi Cui, Yu-Xiang Zhi","doi":"10.3881/j.issn.1000-503X.15915","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.15915","url":null,"abstract":"<p><p>Hereditary angioedema (HAE) is a rare,unpredictable,autosomal dominant disorder characterized by recurrent swelling in subcutaneous and submucosal tissue.In recent years,the pathophysiology and pathogenesis of HAE have been continuously studied and elucidated.In addition to the genes encoding complement 1 esterase inhibitors,new pathogenic variants have been identified in the genes encoding coagulation factor Ⅻ,plasminogen,angiopoietin-1,kininogen,heparan sulfate 3-O-sulfotransferase 6,and myoferlin in HAE.Moreover,different pathogenic variants have different mechanisms in causing HAE.In addition,the pathogenic genes of some patients remain unknown.This review summarizes the recent progress in the classification,epidemiology,pathophysiology,and pathogenesis of HAE,aiming to provide ideas for further fundamental research,clinical diagnosis,and drug development of HAE.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"924-931"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features of Chinese Patients With Bullous Pemphigoid Induced by Immune Checkpoint Inhibitors. 免疫检查点抑制剂诱发大疱性类天疱疮的临床特点
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.16239
Jing-Hui Li, Liu-Yi-Yi Yang, Yan Wang, Ya-Gang Zuo

Objective To explore the clinical features and treatments of Chinese patients with bullous pemphigoid (BP) induced by immune checkpoint inhibitors (ICI). Methods A retrospective analysis was conducted on 18 Chinese patients with ICI-induced BP treated in the Peking Union Medical College Hospital and 14 Chinese patients with this disease reported in the literature.Furthermore,the research data of non-Chinese patients were used for comparison to outline the clinical features and treatment responses of the Chinese patients. Results A total of 32 patients (21 males and 11 females) were enrolled,and all of them presented BP induced by programmed death-1/programmed death ligand-1 inhibitors.Compared with non-Chinese patients,the Chinese patients with ICI-induced BP showed low average ages [(65.2±9.5) years vs. (69.9±10.3) years,P=0.020],increased proportion of BP induced by tislelizumab (28.1% vs. 0,P<0.001),decreased proportions of BP induced by pembrolizumab (18.8% vs. 39.4%,P=0.029) and nivolumab (3.1% vs. 52.8%,P<0.001),and decreased proportion of primary malignant melanoma (9.4% vs. 43.3%,P<0.001).The incidence of pruritus (96.9% vs. 66.1%,P<0.001) and mucosal involvement (59.4% vs. 15.7%,P<0.001) in the Chinese patients were higher than those in the non-Chinese patients.The proportions of the Chinese patients treated with tripterygium glycosides (9.4% vs. 0,P=0.008),dupilumab (18.8% vs. 0.8%,P<0.001),and topical corticosteroids (87.5% vs. 53.5%,P<0.001) were higher than those of non-Chinese patients. Conclusions The Chinese patients with ICI-induced BP tend to have a younger age and a higher probability of BP induced by tislelizumab than the non-Chinese patients.Unlike that in the non-Chinese patients,the primary tumor in the Chinese patients with ICI-induced BP is predominantly lung cancer.Pruritus is more obvious,and mucosal involvement is more common in the Chinese patients.Systemic corticosteroid therapy is the international standard treatment for ICI-induced BP,while tripterygium glycosides and dupilumab are characteristic therapies in China.

目的探讨免疫检查点抑制剂(ICI)诱发大疱性类天疱疮(BP)的临床特点及治疗方法。方法回顾性分析在北京协和医院治疗的18例ici性BP患者和文献报道的14例中国患者的资料。此外,我们还利用非中国籍患者的研究数据进行比较,以概述中国患者的临床特征和治疗反应。结果32例患者(男21例,女11例)均出现程序性死亡-1/程序性死亡配体-1抑制剂所致的BP。与非中国籍患者相比,ici诱导的中国患者平均年龄较低[(65.2±9.5)岁vs(69.9±10.3)岁,P=0.020],替利单抗诱导的BP比例增加(28.1% vs. 0,P =0.020)。39.4%,P=0.029)和纳武单抗(3.1% vs. 52.8%, pv。43.3%, pv。66.1%, pv。15.7%, pv。0,P=0.008),dupilumab (18.8% vs. 0.8%, pv。53.5%, P
{"title":"Clinical Features of Chinese Patients With Bullous Pemphigoid Induced by Immune Checkpoint Inhibitors.","authors":"Jing-Hui Li, Liu-Yi-Yi Yang, Yan Wang, Ya-Gang Zuo","doi":"10.3881/j.issn.1000-503X.16239","DOIUrl":"10.3881/j.issn.1000-503X.16239","url":null,"abstract":"<p><p>Objective To explore the clinical features and treatments of Chinese patients with bullous pemphigoid (BP) induced by immune checkpoint inhibitors (ICI). Methods A retrospective analysis was conducted on 18 Chinese patients with ICI-induced BP treated in the Peking Union Medical College Hospital and 14 Chinese patients with this disease reported in the literature.Furthermore,the research data of non-Chinese patients were used for comparison to outline the clinical features and treatment responses of the Chinese patients. Results A total of 32 patients (21 males and 11 females) were enrolled,and all of them presented BP induced by programmed death-1/programmed death ligand-1 inhibitors.Compared with non-Chinese patients,the Chinese patients with ICI-induced BP showed low average ages [(65.2±9.5) years <i>vs.</i> (69.9±10.3) years,<i>P</i>=0.020],increased proportion of BP induced by tislelizumab (28.1% <i>vs.</i> 0,<i>P</i><0.001),decreased proportions of BP induced by pembrolizumab (18.8% <i>vs.</i> 39.4%,<i>P</i>=0.029) and nivolumab (3.1% <i>vs.</i> 52.8%,<i>P</i><0.001),and decreased proportion of primary malignant melanoma (9.4% <i>vs.</i> 43.3%,<i>P</i><0.001).The incidence of pruritus (96.9% <i>vs.</i> 66.1%,<i>P</i><0.001) and mucosal involvement (59.4% <i>vs.</i> 15.7%,<i>P</i><0.001) in the Chinese patients were higher than those in the non-Chinese patients.The proportions of the Chinese patients treated with tripterygium glycosides (9.4% <i>vs.</i> 0,<i>P</i>=0.008),dupilumab (18.8% <i>vs.</i> 0.8%,<i>P</i><0.001),and topical corticosteroids (87.5% <i>vs.</i> 53.5%,<i>P</i><0.001) were higher than those of non-Chinese patients. Conclusions The Chinese patients with ICI-induced BP tend to have a younger age and a higher probability of BP induced by tislelizumab than the non-Chinese patients.Unlike that in the non-Chinese patients,the primary tumor in the Chinese patients with ICI-induced BP is predominantly lung cancer.Pruritus is more obvious,and mucosal involvement is more common in the Chinese patients.Systemic corticosteroid therapy is the international standard treatment for ICI-induced BP,while tripterygium glycosides and dupilumab are characteristic therapies in China.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"872-882"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Exercise and Dietary Interventions for Peripheral Arterial Disease. 运动和饮食干预外周动脉疾病的研究进展
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.15928
Kai Zheng, Pei-Pei Han

Peripheral arterial disease(PAD)is a common atherosclerotic cardiovascular disease.The patients with this disease experience pain during exercise,which is relieved after rest.Exercise interventions,dietary interventions,and combined interventions can treat PAD via different mechanisms.Aerobic exercise,resistance exercise,and combined exercise can increase muscle strength and improve cardiorespiratory fitness to regulate vascular endothelial adhesion.Dietary interventions,such as dietary fibre,polyunsaturated fatty acids,and antioxidants,can affect plaque formation via anti-inflammatory and antioxidant mechanisms.The combined exercise and dietary interventions can have synergistic effects.This article reviews the relationship between the two interventions and PAD and describes the current status of research on different interventions,providing a scientific basis for the prevention and treatment of PAD.

外周动脉疾病(PAD)是一种常见的动脉粥样硬化性心血管疾病。患有此病的患者在运动时感到疼痛,休息后疼痛减轻。运动干预、饮食干预和联合干预可以通过不同的机制治疗PAD。有氧运动、阻力运动、联合运动均可增加肌肉力量,改善心肺适能,调节血管内皮粘附。饮食干预,如膳食纤维、多不饱和脂肪酸和抗氧化剂,可以通过抗炎和抗氧化机制影响斑块的形成。运动与饮食相结合的干预可以产生协同效应。本文综述了两种干预措施与PAD的关系,并介绍了不同干预措施的研究现状,为PAD的预防和治疗提供科学依据。
{"title":"Advances in Exercise and Dietary Interventions for Peripheral Arterial Disease.","authors":"Kai Zheng, Pei-Pei Han","doi":"10.3881/j.issn.1000-503X.15928","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.15928","url":null,"abstract":"<p><p>Peripheral arterial disease(PAD)is a common atherosclerotic cardiovascular disease.The patients with this disease experience pain during exercise,which is relieved after rest.Exercise interventions,dietary interventions,and combined interventions can treat PAD via different mechanisms.Aerobic exercise,resistance exercise,and combined exercise can increase muscle strength and improve cardiorespiratory fitness to regulate vascular endothelial adhesion.Dietary interventions,such as dietary fibre,polyunsaturated fatty acids,and antioxidants,can affect plaque formation via anti-inflammatory and antioxidant mechanisms.The combined exercise and dietary interventions can have synergistic effects.This article reviews the relationship between the two interventions and PAD and describes the current status of research on different interventions,providing a scientific basis for the prevention and treatment of PAD.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"932-939"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Fertility-Sparing Surgery on Prognosis and Fertility of Patients With Ovarian Borderline Tumors. 保留生育能力手术对卵巢交界性肿瘤患者预后及生育能力的影响。
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.16054
Xiao-Xiao Lin, Lin Tang, Ming-Jie Yang, Bai-Lei Zhang

Objective To compare the safety and efficacy of fertility-sparing surgery in patients with ovarian borderline tumors (BOT). Methods A total of 121 BOT patients undergoing fertility-sparing surgery between January 2010 and October 2022 were retrospectively analyzed.The univariate analysis,multivariate analysis,and survival curves were employed to evaluate the clinicopathological and surgical variables and fertility. Results The 121 BOT patients included in this study showed the 5-year recurrence-free survival (RFS) rate of 65.8% and the recurrence rate of 30.5%.A total of 53 patients attempted to conceive and 40 (33.06%) of the patients achieved successful pregnancy.Different methods of fertility-sparing surgery did not affect the tumor recurrence rate,RFS,or pregnancy rate.The multivariate analysis indicated that the International Federation of Gynecology and Obstetrics (FIGO) stage ≥Ⅱ was an independent risk factor affecting both postoperative recurrence and RFS (P=0.011,OR=6.504,95%CI=1.534-27.58;P=0.033,HR=2.589,95%CI=1.082-6.194) in BOT patients.Tissue type (mucinous) was negatively correlated with the risk of recurrence after fertility-sparing surgery (P=0.011,OR=0.270,95%CI=0.099-0.739).The two unilateral surgical methods showed differences in the amount of intraoperative bleeding (P=0.010),postoperative hospital stay (P=0.001),duration of antibiotic use (P=0.002),and tumor rupture rate (P=0.030),which were not significantly different between the two bilateral surgical methods. Conclusions For young patients with fertility requirements,fertility-sparing surgery is safe and effective.After a comprehensive assessment of clinicopathological factors,unilateral cystectomy and bilateral cystectomy may be recommended as the preferred choice of treatment.For the patients with advanced FIGO stages who strongly prefer fertility sparing,fertility-sparing surgery can be performed with fully informed consent,and these patients should attempt to achieve pregnancy as soon as possible after the surgery.

目的比较保生育手术治疗卵巢交界性肿瘤(BOT)的安全性和有效性。方法回顾性分析2010年1月至2022年10月行保生育手术的121例BOT患者。采用单因素分析、多因素分析和生存曲线评价临床病理和手术变量及生育能力。结果121例BOT患者5年无复发生存率(RFS)为65.8%,复发率为30.5%。53例患者尝试妊娠,40例(33.06%)患者成功妊娠。不同的保生育手术方法对肿瘤复发率、RFS和妊娠率没有影响。多因素分析显示,国际妇产科联合会(FIGO)分期≥Ⅱ是影响BOT患者术后复发和RFS的独立危险因素(P=0.011,OR=6.504,95%CI=1.534-27.58;P=0.033,HR=2.589,95%CI=1.082-6.194)。组织类型(粘液)与保留生育手术后复发风险呈负相关(P=0.011,OR=0.270,95%CI=0.099 ~ 0.739)。两种单侧手术方式术中出血量(P=0.010)、术后住院时间(P=0.001)、抗生素使用时间(P=0.002)、肿瘤破裂率(P=0.030)差异无统计学意义,两种双侧手术方式间差异无统计学意义。结论对于有生育需求的年轻患者,保生育手术是安全有效的。在综合评估临床病理因素后,可能推荐单侧膀胱切除术和双侧膀胱切除术作为首选治疗方法。对于FIGO晚期患者,强烈希望保留生育能力,可以在充分知情同意的情况下进行保留生育手术,这些患者应在手术后尽快实现妊娠。
{"title":"Effects of Fertility-Sparing Surgery on Prognosis and Fertility of Patients With Ovarian Borderline Tumors.","authors":"Xiao-Xiao Lin, Lin Tang, Ming-Jie Yang, Bai-Lei Zhang","doi":"10.3881/j.issn.1000-503X.16054","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.16054","url":null,"abstract":"<p><p>Objective To compare the safety and efficacy of fertility-sparing surgery in patients with ovarian borderline tumors (BOT). Methods A total of 121 BOT patients undergoing fertility-sparing surgery between January 2010 and October 2022 were retrospectively analyzed.The univariate analysis,multivariate analysis,and survival curves were employed to evaluate the clinicopathological and surgical variables and fertility. Results The 121 BOT patients included in this study showed the 5-year recurrence-free survival (RFS) rate of 65.8% and the recurrence rate of 30.5%.A total of 53 patients attempted to conceive and 40 (33.06%) of the patients achieved successful pregnancy.Different methods of fertility-sparing surgery did not affect the tumor recurrence rate,RFS,or pregnancy rate.The multivariate analysis indicated that the International Federation of Gynecology and Obstetrics (FIGO) stage ≥Ⅱ was an independent risk factor affecting both postoperative recurrence and RFS (<i>P</i>=0.011,<i>OR</i>=6.504,95%<i>CI</i>=1.534-27.58;<i>P</i>=0.033,<i>HR</i>=2.589,95%<i>CI</i>=1.082-6.194) in BOT patients.Tissue type (mucinous) was negatively correlated with the risk of recurrence after fertility-sparing surgery (<i>P</i>=0.011,<i>OR</i>=0.270,95%<i>CI</i>=0.099-0.739).The two unilateral surgical methods showed differences in the amount of intraoperative bleeding (<i>P</i>=0.010),postoperative hospital stay (<i>P</i>=0.001),duration of antibiotic use (<i>P</i>=0.002),and tumor rupture rate (<i>P</i>=0.030),which were not significantly different between the two bilateral surgical methods. Conclusions For young patients with fertility requirements,fertility-sparing surgery is safe and effective.After a comprehensive assessment of clinicopathological factors,unilateral cystectomy and bilateral cystectomy may be recommended as the preferred choice of treatment.For the patients with advanced FIGO stages who strongly prefer fertility sparing,fertility-sparing surgery can be performed with fully informed consent,and these patients should attempt to achieve pregnancy as soon as possible after the surgery.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"890-898"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of MRI-Based Ovarian-Adnexal Reporting and Data System for the Diagnosis of Adnexal Masses. 基于mri的卵巢-附件报告与数据系统在附件肿块诊断中的价值。
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.16176
Shan Zhang, Tao Li, Zeng-Fa Huang, Xin-Yu DU, Rui-Yao Tang, Wan-Peng Wang, Xi Wang, Wei Xie, Xiang Wang, Shu-Tong Zhang

Objective To assess the value of the MRI-based ovarian-adnexal reporting and data system (O-RADS MRI) for the diagnosis of adnexal masses. Methods A total of 407 patients who underwent dynamic contrast enhancement (DCE)-MRI and pathological examination (gold standard) at the Department of Radiology,Central Hospital of Wuhan between May 2017 and December 2022 were enrolled in this study.Two radiologists performed the O-RADS MRI scoring of adnexal masses according to MRI features and calculated the malignancy rate of adnexal masses by O-RADS MRI score,enhancement type,and mass type.Moreover,receiver operating characteristic curves were established to further evaluate the diagnostic values of O-RADS MRI score,enhancement type,and mass type for adnexal masses. Results A total of 502 adnexal masses were identified in the 407 patients enrolled in this study,including 364 benign masses and 138 malignant masses (including junctional masses).Radiologist 1 reported the malignancy rates of 0,0,5.4%,80.0%,and 89.7% and radiologist 2 reported the malignancy rates of 0,0,5.8%,86.2%,and 83.0% for the adnexal masses with the O-RADS MRI scores of 1-5,respectively.With O-RADS MRI ≥4 indicating malignant masses,the sensitivity,specificity,accuracy,positive predictive value,negative predictive value,false negative rate,and false positive rate were 94.2%,93.6%,93.8%,84.9%,97.7%,2.3%,and 15.1% for radiologist 1 and 93.4%,93.6%,93.6%,85.4%,97.4%,3.6%,and 14.6% for radiologist 2,respectively.The malignancy rates of the adnexal masses presenting no enhancement,cystic wall enhancement,type Ⅰ curve,type Ⅱ curve,and type Ⅲ curve were 0,1.3%,5.7%,81.2%,and 89.0% as reported by radiologist 1 and 0,1.2%,11.3%,87.6%,and 80.0% as reported by radiologist 2,respectively.The malignancy rates of the adnexal masses that were cystic lesions,cystic segregated lesions,solid lesions,cystic solid lesions,and cystic solid segregated lesions were 0,7.1%,38.7%,79.1%,and 89.8% as reported by radiologist 1 and 0,8.1%,37.8%,72.4%,and 89.6% as reported by radiologist 2,respectively.With type Ⅱ and type Ⅲ curves as the criteria for malignancy,the sensitivity of radiologists 1 and 2 was lower for cystic segregated lesions,both at 50.0%.For the masses containing solid components,radiologists 1 and 2 demonstrated low specificity,which was 57.7% and 56.5%,respectively.False-positive masses contained solid components and were mostly fibroadenomas or adnexal leiomyomas,while false-negative masses were mostly junctional cystadenomas with no or few solid components. Conclusions The O-RADS MRI risk stratification has a high diagnostic value for adnexal masses.Further evaluation and refinement are needed to reduce the false-positive rate.

目的探讨基于MRI的卵巢附件报告与数据系统(O-RADS MRI)对附件肿块的诊断价值。方法选取2017年5月至2022年12月武汉市中心医院放射科行动态对比增强(DCE)-MRI及病理检查(金标准)的407例患者作为研究对象。2名放射科医师根据MRI特征对附件肿物进行O-RADS MRI评分,根据O-RADS MRI评分、增强类型、肿物类型计算附件肿物的恶性率。建立受者工作特征曲线,进一步评价O-RADS MRI评分、增强类型、肿块类型对附件肿块的诊断价值。结果407例患者共发现附件肿块502例,其中良性肿块364例,恶性肿块138例(含交界处肿块)。放射科医师1对O-RADS评分为1-5分的附件肿块的恶性率分别为0、0、5.4%、80.0%、89.7%,放射科医师2对其恶性率分别为0、0、5.8%、86.2%、83.0%。当O-RADS MRI≥4提示恶性肿块时,放射科医师1的敏感性、特异性、准确性、阳性预测值、阴性预测值、假阴性率、假阳性率分别为94.2%、93.6%、93.8%、84.9%、97.7%、2.3%、15.1%,放射科医师2的敏感性、特异性、准确性分别为93.4%、93.6%、93.6%、85.4%、97.4%、3.6%、14.6%。无强化、囊壁强化、Ⅰ曲线型、Ⅱ曲线型、Ⅲ曲线型附件肿块的恶性率由放射科医师1报告为0、1.3%、5.7%、81.2%、89.0%,由放射科医师2报告为0、1.2%、11.3%、87.6%、80.0%。放射科医师1报告的囊性病变、囊性分离性病变、实性性病变、囊性实性性病变、囊性实性分离性病变的恶性率分别为0、7.1%、38.7%、79.1%、89.8%,放射科医师2报告的恶性率分别为0、8.1%、37.8%、72.4%、89.6%。以Ⅱ型和Ⅲ型曲线作为恶性肿瘤的标准,放射科医师1和2对囊性分离病变的敏感性较低,均为50.0%。对于含有固体成分的肿块,放射科医师1和2的特异性较低,分别为57.7%和56.5%。假阳性肿块含实性成分,多为纤维腺瘤或附件平滑肌瘤,假阴性肿块多为交界处囊腺瘤,无或少有实性成分。结论O-RADS MRI危险分层对附件肿块有较高的诊断价值。需要进一步评估和改进以降低假阳性率。
{"title":"Value of MRI-Based Ovarian-Adnexal Reporting and Data System for the Diagnosis of Adnexal Masses.","authors":"Shan Zhang, Tao Li, Zeng-Fa Huang, Xin-Yu DU, Rui-Yao Tang, Wan-Peng Wang, Xi Wang, Wei Xie, Xiang Wang, Shu-Tong Zhang","doi":"10.3881/j.issn.1000-503X.16176","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.16176","url":null,"abstract":"<p><p>Objective To assess the value of the MRI-based ovarian-adnexal reporting and data system (O-RADS MRI) for the diagnosis of adnexal masses. Methods A total of 407 patients who underwent dynamic contrast enhancement (DCE)-MRI and pathological examination (gold standard) at the Department of Radiology,Central Hospital of Wuhan between May 2017 and December 2022 were enrolled in this study.Two radiologists performed the O-RADS MRI scoring of adnexal masses according to MRI features and calculated the malignancy rate of adnexal masses by O-RADS MRI score,enhancement type,and mass type.Moreover,receiver operating characteristic curves were established to further evaluate the diagnostic values of O-RADS MRI score,enhancement type,and mass type for adnexal masses. Results A total of 502 adnexal masses were identified in the 407 patients enrolled in this study,including 364 benign masses and 138 malignant masses (including junctional masses).Radiologist 1 reported the malignancy rates of 0,0,5.4%,80.0%,and 89.7% and radiologist 2 reported the malignancy rates of 0,0,5.8%,86.2%,and 83.0% for the adnexal masses with the O-RADS MRI scores of 1-5,respectively.With O-RADS MRI ≥4 indicating malignant masses,the sensitivity,specificity,accuracy,positive predictive value,negative predictive value,false negative rate,and false positive rate were 94.2%,93.6%,93.8%,84.9%,97.7%,2.3%,and 15.1% for radiologist 1 and 93.4%,93.6%,93.6%,85.4%,97.4%,3.6%,and 14.6% for radiologist 2,respectively.The malignancy rates of the adnexal masses presenting no enhancement,cystic wall enhancement,type Ⅰ curve,type Ⅱ curve,and type Ⅲ curve were 0,1.3%,5.7%,81.2%,and 89.0% as reported by radiologist 1 and 0,1.2%,11.3%,87.6%,and 80.0% as reported by radiologist 2,respectively.The malignancy rates of the adnexal masses that were cystic lesions,cystic segregated lesions,solid lesions,cystic solid lesions,and cystic solid segregated lesions were 0,7.1%,38.7%,79.1%,and 89.8% as reported by radiologist 1 and 0,8.1%,37.8%,72.4%,and 89.6% as reported by radiologist 2,respectively.With type Ⅱ and type Ⅲ curves as the criteria for malignancy,the sensitivity of radiologists 1 and 2 was lower for cystic segregated lesions,both at 50.0%.For the masses containing solid components,radiologists 1 and 2 demonstrated low specificity,which was 57.7% and 56.5%,respectively.False-positive masses contained solid components and were mostly fibroadenomas or adnexal leiomyomas,while false-negative masses were mostly junctional cystadenomas with no or few solid components. Conclusions The O-RADS MRI risk stratification has a high diagnostic value for adnexal masses.Further evaluation and refinement are needed to reduce the false-positive rate.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"909-917"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Progress in Treatment Principles of Acute Closed Soft Tissue Injuries. 急性闭合性软组织损伤治疗原则的研究进展。
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.16073
Bing-Ying Zhang, Xiao-Han Zhang, Yi Qian, Wen-Bo Tang, Feng Gao, Jing-Bin Zhou

This article comprehensively reviews the research progress in the management principles of acute closed soft tissue injuries,summarizing the retention and updates of the four main principles (RICE,PRICE,POLICE,and PEACE&LOVE) at different stages.Traditional methods such as compression,elevation,rest,and protection remain valuable.However,with the advancement in rehabilitation philosophy,early active rehabilitation plays an increasingly important role in the tissue healing process.Traditional cold therapy remains a choice because of its benefits.Non-steroidal anti-inflammatory drugs play a positive role in relieving the acute pain and swelling and improving the function of soft tissue,being preferred by both patients and medical practitioners.Therefore,advantages outweigh disadvantages in the clinical application of non-steroidal anti-inflammatory drugs.Finally,modern medical models have begun to incorporate more social and psychological factors,focusing on patients' mental state and social environment,while guiding patients to actively participate in the rehabilitation process,which can accelerate the recovery process and improve treatment outcomes.

本文综述了急性闭合性软组织损伤管理原则的研究进展,总结了RICE、PRICE、POLICE、PEACE&LOVE四项主要原则在不同阶段的保留与更新。传统的方法,如压缩、抬高、休息和保护仍然有价值。然而,随着康复理念的进步,早期主动康复在组织愈合过程中发挥着越来越重要的作用。传统的冷敷疗法由于其益处仍然是一种选择。非甾体类抗炎药在缓解急性疼痛和肿胀、改善软组织功能方面具有积极作用,受到患者和医生的青睐。因此,非甾体类抗炎药的临床应用利大于弊。最后,现代医学模式开始纳入更多的社会和心理因素,关注患者的心理状态和社会环境,同时引导患者积极参与康复过程,加快康复进程,提高治疗效果。
{"title":"Research Progress in Treatment Principles of Acute Closed Soft Tissue Injuries.","authors":"Bing-Ying Zhang, Xiao-Han Zhang, Yi Qian, Wen-Bo Tang, Feng Gao, Jing-Bin Zhou","doi":"10.3881/j.issn.1000-503X.16073","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.16073","url":null,"abstract":"<p><p>This article comprehensively reviews the research progress in the management principles of acute closed soft tissue injuries,summarizing the retention and updates of the four main principles (RICE,PRICE,POLICE,and PEACE&LOVE) at different stages.Traditional methods such as compression,elevation,rest,and protection remain valuable.However,with the advancement in rehabilitation philosophy,early active rehabilitation plays an increasingly important role in the tissue healing process.Traditional cold therapy remains a choice because of its benefits.Non-steroidal anti-inflammatory drugs play a positive role in relieving the acute pain and swelling and improving the function of soft tissue,being preferred by both patients and medical practitioners.Therefore,advantages outweigh disadvantages in the clinical application of non-steroidal anti-inflammatory drugs.Finally,modern medical models have begun to incorporate more social and psychological factors,focusing on patients' mental state and social environment,while guiding patients to actively participate in the rehabilitation process,which can accelerate the recovery process and improve treatment outcomes.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"828-835"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial Association of Surface Water Quality and Cancer in the Huaihe River Basin. 淮河流域地表水水质与癌症的空间关联
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.16061
Jing Zhao, Wei Han, Xiao-Bo Guo, Lu-Wen Zhang, Fang Xue, Jing-Mei Jiang

Objective To reveal the spatial distribution patterns of key pollutants in the Huaihe River Basin and quantify the risks and burdens of non-gastrointestinal cancers by the grade of pollution,providing targets and data support for enhanced management of water pollution in the Huaihe River Basin. Methods Surface water quality data of the Huaihe River Basin were obtained from the National Surface Water Environmental Quality Monitoring Network(2021).Incidence data of seven cancers were extracted from the 2019 Annual Report of the China Cancer Registry.Random forest and SHapley Additive exPlanations were employed to select key pollutants,and pollution was graded based on the spatial analysis of the Huaihe River Basin.The cancer risks and population attributable fractions were calculated under pollution grades. Results Five key pollutants linked to cancers were identified,including total nitrogen,total phosphorus,chemical oxygen demand,biochemical oxygen demand after 5 days,and arsenic.Pollution was graded into three levels regarding the combined effects of pollutants.Compared with the low pollution areas,high pollution areas showed increased risks of lung cancer(RR=1.26,95%CI:1.06-1.50),breast cancer(female)(RR=1.46,95%CI:1.21-1.77),pancreatic cancer(RR=1.46,95%CI:1.06-2.01),brain cancer(RR=1.44,95%CI:1.05-1.98),and gallbladder cancer(RR=1.60,95%CI:1.03-2.50).The grade of pollution contributed to more than 5% of cases for most cancers above. Conclusions The potential cancer risks and burdens attributed to surface water pollution cannot be overlooked.Addressing this challenge necessitates close collaboration of various stakeholders to strengthen policy development,enhance environmental governance,and implement public health interventions.

目的揭示淮河流域重点污染物的空间分布格局,并通过污染等级量化淮河流域非胃肠道肿瘤的风险和负担,为加强淮河流域水污染治理提供指标和数据支持。方法淮河流域地表水水质数据来源于国家地表水环境质量监测网(2021)。7种癌症的发病率数据摘自2019年中国癌症登记处年度报告。采用随机森林(Random forest)和SHapley加性解释(Additive explanation)选择重点污染物,并在淮河流域空间分析的基础上进行污染分级。根据污染等级计算癌症风险和人群归因分数。结果确定了5种与癌症相关的关键污染物,包括总氮、总磷、化学需氧量、5 d后生化需氧量和砷。根据污染物的综合影响,将污染分为三个级别。与低污染区相比,高污染区肺癌(RR=1.26,95%CI:1.06 ~ 1.50)、乳腺癌(女性)(RR=1.46,95%CI:1.21 ~ 1.77)、胰腺癌(RR=1.46,95%CI:1.06 ~ 2.01)、脑癌(RR=1.44,95%CI:1.05 ~ 1.98)、胆囊癌(RR=1.60,95%CI:1.03 ~ 2.50)的风险增加。以上大多数癌症病例中,超过5%的病例是由上述污染程度造成的。结论地表水污染带来的潜在癌症风险和负担不容忽视。应对这一挑战需要各利益攸关方密切合作,以加强政策制定、加强环境治理和实施公共卫生干预措施。
{"title":"Spatial Association of Surface Water Quality and Cancer in the Huaihe River Basin.","authors":"Jing Zhao, Wei Han, Xiao-Bo Guo, Lu-Wen Zhang, Fang Xue, Jing-Mei Jiang","doi":"10.3881/j.issn.1000-503X.16061","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.16061","url":null,"abstract":"<p><p>Objective To reveal the spatial distribution patterns of key pollutants in the Huaihe River Basin and quantify the risks and burdens of non-gastrointestinal cancers by the grade of pollution,providing targets and data support for enhanced management of water pollution in the Huaihe River Basin. Methods Surface water quality data of the Huaihe River Basin were obtained from the National Surface Water Environmental Quality Monitoring Network(2021).Incidence data of seven cancers were extracted from the 2019 Annual Report of the China Cancer Registry.Random forest and SHapley Additive exPlanations were employed to select key pollutants,and pollution was graded based on the spatial analysis of the Huaihe River Basin.The cancer risks and population attributable fractions were calculated under pollution grades. Results Five key pollutants linked to cancers were identified,including total nitrogen,total phosphorus,chemical oxygen demand,biochemical oxygen demand after 5 days,and arsenic.Pollution was graded into three levels regarding the combined effects of pollutants.Compared with the low pollution areas,high pollution areas showed increased risks of lung cancer(<i>RR</i>=1.26,95%<i>CI</i>:1.06-1.50),breast cancer(female)(<i>RR</i>=1.46,95%<i>CI</i>:1.21-1.77),pancreatic cancer(<i>RR</i>=1.46,95%<i>CI</i>:1.06-2.01),brain cancer(<i>RR</i>=1.44,95%<i>CI</i>:1.05-1.98),and gallbladder cancer(<i>RR</i>=1.60,95%<i>CI</i>:1.03-2.50).The grade of pollution contributed to more than 5% of cases for most cancers above. Conclusions The potential cancer risks and burdens attributed to surface water pollution cannot be overlooked.Addressing this challenge necessitates close collaboration of various stakeholders to strengthen policy development,enhance environmental governance,and implement public health interventions.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"849-861"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral T-Cell Lymphoma Following Treatment of Hodgkin Lymphoma: Report of One Case and Literature Review. 霍奇金淋巴瘤治疗后外周血t细胞淋巴瘤1例报告并文献复习。
Q4 Medicine Pub Date : 2024-12-01 DOI: 10.3881/j.issn.1000-503X.15920
Jun-Xia He, Ming-Feng Jia, Yao-Jia Hu, Xi-Yuan Jiang, Ya-Ming Xi

This article reports a patient with peripheral T cell lymphoma following treatment of Hodgkin lymphoma.The biopsy of cervical lymph node initially confirmed classic Hodgkin lymphoma,with Reed-Sternberg cells expressing CD30 and B cell-specific activator.After 2 years,the disease progressed and the patient was diagnosed with peripheral T-cell lymphoma (non-specific type) by lymph node biopsy,with the expression of CD3,CD4,and CD8.The patient was undergoing chemotherapy in November 2023.

本文报告一例霍奇金淋巴瘤治疗后的外周T细胞淋巴瘤。颈部淋巴结活检最初证实为经典霍奇金淋巴瘤,Reed-Sternberg细胞表达CD30和B细胞特异性激活剂。2年后,病情进展,经淋巴结活检诊断为外周t细胞淋巴瘤(非特异性),CD3、CD4、CD8表达。该患者于2023年11月接受化疗。
{"title":"Peripheral T-Cell Lymphoma Following Treatment of Hodgkin Lymphoma: Report of One Case and Literature Review.","authors":"Jun-Xia He, Ming-Feng Jia, Yao-Jia Hu, Xi-Yuan Jiang, Ya-Ming Xi","doi":"10.3881/j.issn.1000-503X.15920","DOIUrl":"10.3881/j.issn.1000-503X.15920","url":null,"abstract":"<p><p>This article reports a patient with peripheral T cell lymphoma following treatment of Hodgkin lymphoma.The biopsy of cervical lymph node initially confirmed classic Hodgkin lymphoma,with Reed-Sternberg cells expressing CD30 and B cell-specific activator.After 2 years,the disease progressed and the patient was diagnosed with peripheral T-cell lymphoma (non-specific type) by lymph node biopsy,with the expression of CD3,CD4,and CD8.The patient was undergoing chemotherapy in November 2023.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 6","pages":"965-969"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国医学科学院学报
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1